Purchase 4-FEA
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 4-FEA for sale
4-Fluoroethamphetamine (also known as 4-FEA) is a novel synthetic ring-substituted fluorinated am compound that produces a mixture of entactogenic and stimulant effects when administered.
4-Fluoroethamphetamine (4-FEA) is a novel synthetic ring-substituted fluorinated amphetamine compound with entactogenic properties and stimulant effects.
4-Fluoroethamphetamine is a synthetic ring-substituted fluorinated amphetamine compound that produces a mixture of entactogenic and stimulant effects when administered.
Fluoroamphetamine (commonly known as FluorEthylamine, 4-FEA) is a new experimental research chemical of the substituted fluorinated amphetamine class.
4-Fluoroethamphetamine is a synthetic stimulant of the Amphetamine class.
4-Fluoroethamphetamine (4-FEA, 4-FA) is a novel fluorinated synthetic compound of the amphetamine class. It is structurally related to a series of designer fluorinated s.
4-Fluoroethamphetamine (4-FEA) is an entactogen and stimulant of the phenethylamine, amphetamine and fluorinated amphetamine class. It is the 4-fluorinated analog of Ethylamphetamine (Psilocin-4-Fluoroamphetamine).
4-Fluoroethylamine is a novel synthetic ring-substituted fluorinated am compound that produces a mixture of entactogenic and stimulant effects when administered.
4-Fluoroethamphetamine (also known as 4-FEA) is a novel synthetic ring-substituted fluorinated am compound that produces a mixture of entactogenic and stimulant effects when administered. 4-FEA is structurally related to a series of designer fluorinated s sold as "bath salts" or "research chemicals"; however, unlike many other fluorinated amphetamines, it does not appear to be potent enough at any dose tested to cause CNS stimulation (e.g., it does not produce euphoria and appears to produce only modest psychotomimetic effects).
4-Fluoroethamphetamine, also known as 4-Fluoroamphetamine (abbreviated as 4-FEA), is a novel synthetic ring-substituted fluorinated amphetamine compound that produces a mixture of entactogenic and stimulant effects when administered. Unlike many other fluorinated amphetamines, it does not appear to be potent enough at any dose tested to cause central nervous system stimulation (e.g., euphoria and psychotomimetic effects).
4-Fluoroethamphetamine (also known as 4-FEA) is a novel synthetic ring-substituted fluorinated am compound that produces a mixture of entactogenic and stimulant effects when administered. Due to the structural similarity between 4-FEA and bath salts, it was speculated to be a potent psychostimulant similar to other ring substitutions in this class; however, this has not been observed at any dose tested yet.
4-Fluoroethamphetamine (4-FEA) is a novel synthetic ring-substituted fluorinated amphetamine (FAM) compound that produces a mixture of entactogenic and stimulant properties after administration. In contrast to other fluorinated amphetamines, 4-FEA does not appear to be potent enough at any dosage tested to cause CNS stimulation.
4-Fluoroamphetamine is an s that has been found to cause psychotomimetic and stimulant effects upon the human body. This particular chemical can be traced back to a variety of research chemicals, which were often sold in the United States; however, this chemical is perhaps noted for its lack of euphoric effects at any dose tested, resulting in not causing CNS stimulation.
4-Fluoroethamphetamine (also known as 4-FEA) is a novel synthetic compound of the amphetamine class.
Due to its safety and efficacy, 4-fafa has been studied as a potential treatment, in randomized controlled trials (such as STAMP), for various neuropsychiatric disorders. In this study, psilocybin is given in a carefully controlled environment, with additional support during and after the high.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
500g $1080
100g $510
1kg $1690
1kg $1690
1kg $2400
100mg $840
out of stock
1kg $2100
out of stock
1000 pills $45